Protecting the ocular surface and improving the quality of life of dry eye patients: A study of the efficacy of an HP-guar containing ocular lubricant in a population of dry eye patients

Journal of Ocular Pharmacology and Therapeutics

Volumn 25, Issue 3, 2009, Pages 271-277

  Rolando, Maurizio ^a,b   Autori, Silvia ^a   Badino, Francesco ^a   Barabino, Stefano ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL TEAR; HYDROXYPROPYLGUAR; LUBRICATING AGENT; MACROGOL 400; PROPYLENE GLYCOL; SYSTANE; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BLINKING; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONJUNCTIVA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA; DISEASE SEVERITY; DRUG EFFICACY; DRUG FORMULATION; DRUG SELF ADMINISTRATION; DRY EYE; EYE PROTECTION; GLOBAL STAINING SCORE; HUMAN; OCULAR PROTECTION INDEX; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; TEAR FILM; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADULT; AGED; DRUG COMBINATIONS; DRY EYE SYNDROMES; HUMANS; MIDDLE AGED; OPHTHALMIC SOLUTIONS; POLYETHYLENE GLYCOLS; POLYSACCHARIDES; PROPYLENE GLYCOL; PROSPECTIVE STUDIES; QUALITY OF LIFE; SURFACE-ACTIVE AGENTS; TREATMENT OUTCOME;

EID: 66249145021     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2008.0026     Document Type: Article

References (32)

1. McCarty, C.A., Bansal, A.K., Livingston, P.M., et al. The epidemiology of dry eye in Melbourne, Australia. Ophthalmology 105:1114 -1119, 1998.
2. Schein, O.D., Munoz, B., Tielsch, J.M., et al. Prevalence of dry eye among the elderly. Am. J. Ophthalmol. 124:723-728, 1997.
3. Doughty, M.J., Fonn, D., Richter, D., et al. A patient questionnaire approach to estimating the prevalence of dry eye symptoms in patients presenting to optometric practices across Canada. Optom. Vis. Sci. 74:624-631, 1997.
4. Schaumberg, D.A., Sullivan, D.A., Buring, J.E., et al. Prevalence of dry eye syndrome among US women. Am. J. Ophthalmol. 136(2):318-326, 2003.
5. Lemp, M.A., Foulks, G.N., Devgan, U., et al. The therapeutic role of lipids: managing ocular surface disease. Refract. Eyecare Ophthamol. 9(Suppl):3-15, 2005.
6. Gilbard, J.P. Dry eye, blepharitis and chronic eye irritation: divide and conquer. J. Ophthalmic. Nurs. Technol. 18:109-115, 1999.
7. Holly, F.J., Lemp, M.A. Tear physiology and dry eyes. Surv. Ophthalmol. 22:69-87, 1977.
8. Tsubota, K., Nakamori, K. Dry eyes and video display terminals. N. Engl. J. Med. 328:584, 1993.
9. Fox, R.I., Howell, H.V., Bone, R.C., et al. Primary Sjögren's syndrome: clinical and immunopathologic features. Semin Arthritis Rheumatol. 14:77-105, 1984.
10. Chalmers, R.L., Begley, C.G., Edrington, T., et al. The agreement between self-assessment and clinician assessment of dry eye sensitivity. Cornea 24:804-810, 2005.
11. Foulks, G. The correlation between the tear film lipid layer and dry eye disease. Surv. Ophthalmol. 52:369-374, 2007.
12. The def nition and classif cation of dry eye disease: report of the Def nition and Classif cation Subcommittee of the International Dry Eye Workshop (DEWS). Ocul. Surf. 5:75-92, 2007.
13. Donshik, P.C., Nelson, J.D., Abelson, M., et al. Effectiveness of Bion tears, Cellufresh, Aquasite, and Refresh Plus for moderate to severe dry eye. In: D.A. Sullivan, ed. Lacrimal gland, tear film, and dry eye syndromes. New York: Plenum Press, 1998.
14. Ubels, J.L., Clousing, D.P., Van Haitsma, T.A., et al. Pre-clinical investigation of the eff cacy of an artif cial tear solution containing hydroxypropyl-guar as a gelling agent. Curr. Eye Res. 28:437-444, 2004.
15. Yamada, M., Mochizuki, H., Kawai, M., et al. Fluorophotometric measurement of pH of human tears in vivo. Curr. Eye Res. Opin. 16:482-486, 1997.
16. Christensen, M.T., Cohen, S., Rinehart, J., et al. Clinical evaluation of an HP-guar gellable lubricant eye drop for the relief of dryness of the eye. Curr. Eye Res. Opin. 28:55-62, 2004.
17. Hartstein, I., Khwarg, S., Przydryga, J. An open-label evaluation of HP-Guar gellable lubricant eye drops for the improvement of dry eye signs and symptoms in a moderate dry eye adult population. Curr. Med. Res. Opin. 21:255-260, 2005.
18. Versura, P., Profazio, V., Campos, E.C. Ocular surface in dry eye patients is improved after one month therapy with Systane. Acta Ophthalmologica Scandinavica 85(s240), 2007.
19. Meyer, A.E., Baier, R.E., Chen, H., et al. Differential tissue-on-tissue lubrication by ophthalmic formulations. J. Biomed. Mat. Res.: Appl. Biomat. 82(Part B):74-88, 2007.
20. Ousler, G.W., Michaelson, C., Christensen, M.T. An evaluation of tear film breakup time extension and Ocular Protection Index scores among three marketed lubricant eye drops. Cornea 26:949-952, 2007.
21. Gifford, P., Evans, B.J.W., Morris, J. A clinical evaluation of Systane. Contact Lens Anter. Eye. 29:31-40, 2006.
22. Ousler, G.W., Emory, T.B., Welch, D., et al. Factors that inf uence the inter-blink interval (IBI) as measured by the ocular protection index (OPI). Invest. Ophthalmol. Vis. Sci. 43: E-Abstract 56, 2002.
23. Ousler, G.W. III, Hagberg, K.W., Schindelar, M., et al. The Ocular Protection Index. Cornea. 27:509-513, 2008.
24. Cheng, Y., Brown, K.M., Prud'homme, R.K. Characterization an intermolecular interactions of hydroxypropyl guar solutions. Biomacromolecules. 3:456-461, 2002.
25. Asgharian, B., Nolen, L., Meadows, D., et al. Novel gel-forming ophthalmic polymer system for artif cial tear solution. Invest. Ophthalmol. Vis. Sci. 44: E-Abstract 2472, 2003.
26. Guillon, M., Chamberlain, P., Marks, M.G., et al. Effect of eye drop compositional characteristics on tear film. Invest. Ophthalmol. Vis. Sci. 45:E-Abstract 3878, 2004.
27. Nichols, K.K., Nichols, J.J., Mitchell, G.L. The lack of association between signs and symptoms in patients with dry eye disease. Cornea. 23:762-770, 2004.
28. Ousler, G.W. III, Kellerman, D., Durham, T., et al. A correlation between central corneal staining and dry eye symptomatology. Invest. Ophthalmol. Vis. Sci. 47:E-Abstract 281, 2006.
29. Schindelar, M., Ousler, G.W. III, Abelson, M.B. Effect of tear film stability on ocular surface damage in a population of dry eye patients. Invest. Ophthalmol. Vis. Sci. 46: E-Abstract 4457, 2005.
30. Ousler, G.W., Emory, T.B., Welch, D., et al. Factors that inf uence the inter-blink interval (IBI) as measured by the ocular protection index (OPI). Invest. Ophthalmol. Vis. Sci. 43:E-Abstract 56, 2002.
31. Nakamori, K., Odawara, M., Nakajima, T., et al. Blinking is controlled primarily by ocular surface conditions. Am. J. Ophthalmol. 124:24-30, 1997.
32. Nally, L., Ousler, G.W., Emory, T.B., et al. A correlation between blink rate and corneal sensitivity in a dry eye population. Invest. Ophthalmol. Vis Sci. 44:E-Abstract 2488, 2003.